Kolmar BioTech, Inc. (KOSDAQ:215380)
South Korea · Delayed Price · Currency is KRW 2,070.00
-5.00 (-0.24%)
At close: Oct 23, 2026
Kolmar BioTech Market Cap
Kolmar BioTech has a market cap or net worth of 34.84 billion as of October 23, 2026. It is the 34,797th most valuable company in the world and the 2,039th biggest in South Korea. Its market cap has increased by 18.97% in one year.
Market Cap
34.84B
Enterprise Value
50.55B
Revenue
40.30B
Global Rank
Country Rank
#2,039 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 27, 2017, Kolmar BioTech's market cap has decreased from 51.29B to 34.84B, a decrease of -32.08%. That is a compound annual growth rate of -3.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 34.84B | 17.55% |
| Dec 30, 2025 | 29.64B | 3.59% |
| Dec 30, 2024 | 28.61B | 5.65% |
| Dec 28, 2023 | 27.08B | -29.98% |
| Dec 29, 2022 | 38.68B | -52.23% |
| Dec 30, 2021 | 80.97B | -29.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 315.98B |
| HLB bioStep | 112.35B |
| DreamCIS | 102.46B |
| P&K Skin Research Center | 49.10B |
| DT&CRO CO. | 27.42B |
| SLS BIO | 26.89B |
| C&R Research | 25.80B |
| Curachem | 12.65B |